IP Verse

Treatment Of Solid Tumours With Rapamycin Derivatives - EP2269603

PATENT ANALYSIS

Patent Details

Grant Date
May 20, 2015
Company
NOVARTIS AG
Oppositions

ACTAVIS PTC EHF

ETHYPHARM

GENERICS [UK] LIMITED

INTAS PHARMACEUTICALS LTD.

STADA ARZNEIMITTEL AG

SYNTHON B.V.

TEVA PHARMACEUTICALS INC.

WITTKOPP, ALEXANDER

ZENTIVA FRANCE

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you